Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Oral Darinaparsin (ZIO-101-C) in Advanced Solid Tumors and Non-Hodgkin's Lymphomas

NCT00591422 is registered in ClinicalTrials.gov with Alaunos Therapeutics as lead sponsor.

NCT NCT00591422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00591422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Oral Darinaparsin (ZIO-101-C) in Advanced Solid Tumors and Non-Hodgkin's Lymphomas
Lead sponsor
Alaunos Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2007
Completion date
March 10, 2011
Enrollment
23 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer